Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype

DOI: 10.1080/2162402X.2015.1067744

Keywords: Angiotensin converting enzyme inhibitor, Angiotensin II type 1 receptor antagonist, Angiotensin II, Innate immunity, Myeloid-derived suppressor cell, neutrophil, tumor immunology

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text